High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification
- 22 January 2021
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 105 (3) , 1051-1062
Abstract
Heparosan is a naturally occurring non-sulfated glycosaminoglycan. Heparosan serves as the substrate for chemoenzymatic synthesis of biopharmaceutically imKeywords
Funding Information
- National Institutes of Health (CA231074)
This publication has 51 references indexed in Scilit:
- Draft Genome Sequence of Escherichia coli Strain ATCC 23506 (Serovar O10:K5:H4)Microbiology Resource Announcements, 2013
- Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1)Microbiology Resource Announcements, 2013
- Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight HeparinsScience, 2011
- Structural characterization of heparins from different commercial sourcesAnalytical and Bioanalytical Chemistry, 2011
- Control of the heparosan N-deacetylation leads to an improved bioengineered heparinApplied Microbiology and Biotechnology, 2011
- High cell density cultivation of Escherichia coli K4 in a microfiltration bioreactor: a step towards improvement of chondroitin precursor productionMicrobial Cell Factories, 2011
- Hyphenated techniques for the analysis of heparin and heparan sulfateAnalytical and Bioanalytical Chemistry, 2010
- E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursorBiotechnology and Bioengineering, 2010
- Analysis of E. coli K5 capsular polysaccharide heparosanAnalytical and Bioanalytical Chemistry, 2010
- Regulation of Expression of the Region 3 Promoter of theEscherichia coliK5 Capsule Gene Cluster Involves H-NS, SlyA, and a Large 5′ Untranslated RegionJournal of Bacteriology, 2009